Antioncogenes and human cancer.

The antioncogenes, or tumor suppressor genes, as negative regulators of cell division, stand in contrast to oncogenes. For most human cancers, the more frequently mutated genes are the antioncogenes, the principal exception being the leukemias and lymphomas. Persons heterozygous for germ-line mutations in antioncogenes are strongly predisposed to one or more kinds of cancer, and most dominantly inherited cancer is attributable to such heterozygosity. Seven antioncogenes have been cloned through the study of these persons, and several others have been mapped. An eighth one was mapped and cloned through the investigation of tumors and is not yet known in hereditary form. Three dominantly inherited forms of cancer are not attributable to mutations in antioncogenes. The corresponding nonhereditary forms of most cancers generally reveal abnormalities of the same antioncogenes that are found in the hereditary forms but may also show additional ones. Some cancers, especially the embryonal tumors of children, have a small number of antioncogene mutations; some others, such as most sarcomas, have more, and the common carcinomas have the most, reflecting a hierarchy of controls over growth of stem cell populations. Still more members of this gene category remain to be mapped and cloned through the study of cancer families and of tumors. The genes that have been cloned act at diverse points in the signal transduction pathway in cells, from the outer cell membranes to sites of gene transcription, in some cases as negative regulators of oncogene expression.

[1]  C. Mathew,et al.  Deletion of genes on chromosome 1 in endocrine neoplasia , 1987, Nature.

[2]  C. Larsson,et al.  Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma , 1988, Nature.

[3]  J. Haines,et al.  A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor , 1993, Cell.

[4]  S. Steinberg,et al.  Nonrandom structural and numerical chromosome changes in non‐small‐cell lung cancer , 1991, Genes, chromosomes & cancer.

[5]  K. Kinzler,et al.  Erratum: Multiple Intestinal Neoplasia Caused By a Mutation in the Murine Homolog of the APC Gene , 1992, Science.

[6]  J. Allalunis-Turner,et al.  Absence of IFNA and IFNB genes from human malignant glioma cell lines and lack of correlation with cellular sensitivity to interferons. , 1990, Cancer research.

[7]  A. Knudson.  Retinoblastoma: a prototypic hereditary neoplasm. , 1978, Seminars in oncology.

[8]  J. Wålinder,et al.  FAMILIAL BRAIN TUMOUR , 1979, The Lancet.

[9]  S. Hinrichs,et al.  Structural evidence for the authenticity of the human retinoblastoma gene. , 1987, Science.

[10]  B. Vogelstein,et al.  Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.

[11]  A. Knudson,et al.  Model for the incidence of embryonal cancers: application to retinoblastoma. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Malkin,et al.  p53 and the Li-Fraumeni syndrome. , 1994, Biochimica et biophysica acta.

[13]  L. Holmes,et al.  A child with 18q- syndrome and cerebellar astrocytoma. , 1983, The Journal of pediatrics.

[14]  R. Weksberg,et al.  Disruption of insulin–like growth factor 2 imprinting in Beckwith–Wiedemann syndrome , 1993, Nature genetics.

[15]  R. Narayanan,et al.  Persistent expression of the tumor suppressor gene DCC is essential for neuronal differentiation. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[16]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[17]  J. Minna,et al.  p53: a frequent target for genetic abnormalities in lung cancer. , 1989, Science.

[18]  Barry F. Smith,et al.  Loss of NF1 alleles in phaeochromocytomas from patients with type 1 neurofibromatosis , 1992, Genes, chromosomes & cancer.

[19]  B. Brownstein,et al.  Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. , 1990, Science.

[20]  S. Pulst,et al.  Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 , 1993, Nature.

[21]  M. King,et al.  Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.

[22]  D. Comings.  A general theory of carcinogenesis. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[23]  F. Berthold,et al.  Neuroblastoma consensus deletion maps to 1p36.1–2 , 1989, Genes, chromosomes & cancer.

[24]  B. Vogelstein,et al.  p53 functions as a cell cycle control protein in osteosarcomas , 1990, Molecular and cellular biology.

[25]  D. Housman,et al.  Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor-suppressor gene(s). , 1993, American journal of human genetics.

[26]  A. Knudson.  Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[27]  David Housman,et al.  WT-1 is required for early kidney development , 1993, Cell.

[28]  Stephen H. Friend,et al.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.

[29]  Y. Nakamura,et al.  Inactivation of both APC alleles in an early stage of colon adenomas in a patient with familial adenomatous polyposis (FAP). , 1992, Human molecular genetics.

[30]  P. Rowley,et al.  Molecular genetic analysis of tumors in von recklinghausen neurofibromatosis: Loss of heterozygosity for chromosome 17 , 1989, Genes, chromosomes & cancer.

[31]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[32]  T. Mikkelsen,et al.  Clonal expansion of p53 mutant cells is associated with brain tumour progression , 1992, Nature.

[33]  O. Olopade,et al.  Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. , 1993, Cancer research.

[34]  W. Lee,et al.  Molecular characterization of the retinoblastoma susceptibility gene. , 1993, Biochimica et biophysica acta.

[35]  D. Ledbetter,et al.  The aniridia-Wilms tumor association: The critical role of chromosome band 11p13☆ , 1980 .

[36]  P. Green,et al.  Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. , 1989, The New England journal of medicine.

[37]  A. Knudson,et al.  Mutation and cancer: a model for Wilms' tumor of the kidney. , 1972, Journal of the National Cancer Institute.

[38]  Bert Vogelstein,et al.  APC mutations occur early during colorectal tumorigenesis , 1992, Nature.

[39]  A. Bradley,et al.  Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis , 1992, Nature.

[40]  K. Kinzler,et al.  Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.

[41]  Knudson Ag.  Stem cell regulation, tissue ontogeny, and oncogenic events. , 1992 .

[42]  A. Berns,et al.  Requirement for a functional Rb-1 gene in murine development , 1992, Nature.

[43]  A. Knudson,et al.  Mutation and cancer: neuroblastoma and pheochromocytoma. , 1972, American journal of human genetics.

[44]  T. Pawson,et al.  High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene , 1989, Molecular and cellular biology.

[45]  D. Housman,et al.  Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus , 1990, Cell.

[46]  G. S. Sekhon,et al.  Chromosomal aberrations in human neuroblastomas , 1977, Cancer.

[47]  A. Friedman,et al.  Loss of heterozygosity for 10q loci in human gliomas , 1992, Genes, chromosomes & cancer.

[48]  J. Gordon,et al.  The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system , 1992, The Journal of cell biology.

[49]  D. Easton,et al.  Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild–type chromosome , 1992, Nature Genetics.

[50]  M. Eccles,et al.  Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour , 1993, Nature.

[51]  J. Sherley.  Guanine nucleotide biosynthesis is regulated by the cellular p53 concentration. , 1991, The Journal of biological chemistry.

[52]  J. Kirkwood,et al.  Homozygous deletions within human chromosome band 9p21 in melanoma. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[53]  A. Poustka,et al.  Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping , 1990, Nature.

[54]  B. Ponder,et al.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A , 1993, Nature.

[55]  K. Kinzler,et al.  The APC gene product in normal and tumor cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[56]  K. Kinzler,et al.  Association between wild type and mutant APC gene products. , 1993, Cancer research.

[57]  Kathleen R. Cho,et al.  Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.

[58]  U. Francke,et al.  Sporadic bilateral retinoblastoma and 13q- chromosomal deletion. , 1976, Medical and pediatric oncology.

[59]  Margaret Robertson,et al.  The neurofibromatosis type 1 gene encodes a protein related to GAP , 1990, Cell.

[60]  P. O'Connell,et al.  A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations , 1990, Cell.

[61]  P. L. Chen,et al.  Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. , 1988, Science.

[62]  Wen-Hwa Lee,et al.  The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity , 1987, Nature.

[63]  C. Mathew,et al.  A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10 , 1987, Nature.

[64]  A. Knudson,et al.  Spontaneous and radiation-induced renal tumors in the Eker rat model of dominantly inherited cancer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[65]  J. Weber,et al.  Genetic mapping of a locus predisposing to human colorectal cancer. , 1993, Science.

[66]  Jeng-Shin Lee,et al.  Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[67]  S. Jacobs,et al.  Hereditary renal-cell carcinoma associated with a chromosomal translocation. , 1979, The New England journal of medicine.

[68]  J. Fraumeni,et al.  Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. , 1969, Journal of the National Cancer Institute.

[69]  M. Greene,et al.  Developmental defects in gorlin syndrome related to a putative tumor suppressor gene on chromosome 9 , 1992, Cell.

[70]  J. Rowley,et al.  Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[71]  P. O’Connell,et al.  The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21 , 1990, Cell.

[72]  O. Wiestler,et al.  Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus , 1991, The Lancet.

[73]  F. Rauscher,et al.  The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[74]  J. Gnarra,et al.  Identification of the von Hippel-Lindau disease tumor suppressor gene. , 1993, Science.

[75]  Margaret Robertson,et al.  Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.

[76]  T. Beaty,et al.  Mendelian inheritance of familial prostate cancer. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[77]  W. Cavenee,et al.  Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. , 1989, American journal of human genetics.

[78]  M. Lipkin,et al.  Proliferative patterns in colonic mucosa in familial polyposis , 1975, Cancer.

[79]  B. Vogelstein,et al.  No room at the p53 inn , 1993, Nature.

[80]  R. Weinberg,et al.  Effects of an Rb mutation in the mouse , 1992, Nature.

[81]  M. Wigler,et al.  The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins , 1990, Cell.

[82]  H. Kastendieck,et al.  Cytogenetic survey of 32 cancers of the prostate. , 1993, Cancer genetics and cytogenetics.

[83]  T. Glover,et al.  Molecular and cytogenetic analysis of tumors in von recklinghausen neurofibromatosis , 1991, Genes, chromosomes & cancer.

[84]  K. Kinzler,et al.  Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.

[85]  S N Thibodeau,et al.  Microsatellite instability in cancer of the proximal colon. , 1993, Science.

[86]  E. Zackai,et al.  Constitutional 1p36 deletion in a child with neuroblastoma. , 1993, American journal of human genetics.

[87]  P. Walsh,et al.  Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. , 1993, Cancer research.

[88]  J. Minna,et al.  Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. , 1988, Science.

[89]  A. Knudson,et al.  Susceptibility to renal carcinoma in the Eker rat involves a tumor suppressor gene on chromosome 10. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[90]  W. W. Nichols,et al.  Chromosomal deletion and retinoblastoma. , 1976, The New England journal of medicine.

[91]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[92]  A. Feinberg,et al.  Relaxation of imprinted genes in human cancer , 1993, Nature.

[93]  T. P. Dryja,et al.  Expression of recessive alleles by chromosomal mechanisms in retinoblastoma , 1983, Nature.

[94]  Darryl Shibata,et al.  Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis , 1993, Nature.